Pilot Study of Erlotinib for the Treatment of Patients With de Novo Acute Myeloid Leukemia

Leukemia, Myelomonocytic, Acute Clinical Trial

Official title:
Pilot Study of Erlotinib for the Treatment of Patients With de Novo Acute Myeloid Leukemia

Status Completed

Clinical Trial Summary

This research study is looking for patients with newly diagnosed acute myeloid leukemia (AML), AML that has returned (relapsed), or it has not responded adequately to previous treatments. Treating certain patients with chemotherapy may not be to their benefit or may cause more harm than benefit. The purpose of this study is to find out what effects (good and bad) erlotinib has on patients and their AML.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01174043
Study type	Interventional
Source	Indiana University
Contact
Status	Completed
Phase	Phase 2
Start date	July 2010
Completion date	March 2012

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00363974` - Study of XIAP Antisense Given With Chemotherapy for Refractory/Relapsed AML	Phase 1/Phase 2
Withdrawn	`NCT02527174` - A Study of Volasertib Plus Induction Chemotherapy for Acute Myeloid Leukemia	Phase 1
Recruiting	`NCT04687657` - Umbilical Cord Blood Transfusion in Consolidation Therapy of Elderly Patients With Acute Myeloid Leukemia	Phase 1